Fetal Hypoxia
1
Pipeline Programs
1
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Raydiant OximetryCA - San Ramon
4 programs1
Fetal Oxygenation MeasurementsPhase 11 trial
Dual fetal oxygen sensorsN/A1 trial
Fetal Pulse OximeteryN/A1 trial
GEN 3 Monitoring of FetusN/A1 trial
Active Trials
+1 more trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Raydiant OximetryFetal Oxygenation Measurements
Raydiant OximetryFetal Pulse Oximetery
Raydiant OximetryDual fetal oxygen sensors
Raydiant OximetryGEN 3 Monitoring of Fetus
Clinical Trials (4)
Total enrollment: 90 patients across 4 trials
Trans-Abdominal Fetal Pulse Oximetry - EFS-IDE
Start: Apr 2024Est. completion: Oct 202535 patients
Phase 1Completed
Dual System Study: Transvaginal Fetal Pulse Oximetry Measurement Systems
Start: Dec 2025Est. completion: Apr 202615 patients
N/ARecruiting
Trans-abdominal Fetal Pulse Oximetry
Start: Jul 2022Est. completion: Nov 202331 patients
N/ATerminated
Trans-abdominal Fetal Pulse Oximetry; Tissue Light Scattering and Signal Integrity
Start: Apr 2021Est. completion: Nov 20259 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 90 patients
1 companies competing in this space